Log In
BCIQ
Print this Print this
 

Sinogliatin (HMS5552, RO5305552)

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionSmall molecule glucokinase (GCK; GK) activator
Molecular Target Glucokinase (GCK) (GK)
Mechanism of ActionGlucokinase activator
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation
PartnerHua Medicine Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/02/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today